Conciseness

The body is dense and directive with no over-explanation of known concepts, but includes unnecessary duplication: the "Summary" section restates the eight analysis phases nearly verbatim from the Phases Overview, and the inline report skeleton duplicates content delegated to report-template.md. This matches the 3 anchor ("could be tightened") rather than 4 because the duplication is a noticeable, removable token cost.

Actionability

Guidance is mostly executable: concrete tool names per phase (e.g., `OpenTargets_get_disease_id_description_by_name`), a parameter table with examples, explicit thresholds ("Filter FDR < 0.05", "Cross-database validation 3+ DBs"), and a report filename convention. It falls short of 5 because no example tool invocations or Python snippets appear inline to cover the common cases.

Workflow Clarity

Nine phases are clearly sequenced with Phase 0 marked "ALWAYS FIRST" and conditional gating ("Cancer/Inflammation only", "if data available"), plus a completeness checklist as an end checkpoint. Not 5: there is no explicit validate/retry loop or fallback guidance at the phase level — fallback strategies are only deferred to tool-reference.md without per-phase pointers; not 3: sequence and most checkpoints are present.

Progressive Disclosure

References are well-signaled and one level deep ("See **phase-procedures.md** for detailed workflows", "See **report-template.md** for full template", plus a Reference Files section with descriptions). Not 5: the HuBMAP tool parameter table and the full report skeleton arguably belong in the referenced files rather than inline, and the five referenced files are not present in this bundle, so the structure could not be verified against actual files.

Specificity

The description lists multiple specific concrete actions — "Transforms spatially variable genes (SVGs), domain annotations, and tissue context into biological insights via domain-by-domain characterization, cell-type composition, spatial gene expression patterns, RNA+protein+metabolite integration" — with comprehensive coverage in third person voice. It matches the 5 anchor rather than 4 because coverage of actions is comprehensive, with no notable gaps.

Completeness

It explicitly answers both "what" (transforms SVGs, domain annotations, and tissue context into biological insights via named methods) and "when" ("Use for Visium, MERFISH, seqFISH, Slide-seq, spatial proteomics, and spatial multi-omics interpretation") with concrete trigger phrases, matching the 5 anchor exactly.

Trigger Term Quality

Trigger terms include "Use for Visium, MERFISH, seqFISH, Slide-seq, spatial proteomics, and spatial multi-omics interpretation" — strong platform coverage users would naturally say. It falls short of 5 because common natural synonyms such as "spatial transcriptomics" and "spatial domains" are missing; it is above 3 because keyword coverage is good rather than partial.

Distinctiveness Conflict Risk

The niche (spatial multi-omics interpretation) is clear and the platform-name triggers (Visium, MERFISH, seqFISH, Slide-seq) are highly distinctive, giving minimal conflict risk with adjacent gene/variant/drug-safety skills it explicitly excludes.